190 related articles for article (PubMed ID: 17358032)
1. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV.
Witt KL; Cunningham CK; Patterson KB; Kissling GE; Dertinger SD; Livingston E; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):322-9. PubMed ID: 17358032
[TBL] [Abstract][Full Text] [Related]
2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
Dryden-Peterson S; Shapiro RL; Hughes MD; Powis K; Ogwu A; Moffat C; Moyo S; Makhema J; Essex M; Lockman S
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):428-36. PubMed ID: 21266910
[TBL] [Abstract][Full Text] [Related]
5. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Landay AL; Baker R; Stek AM; Khoury MM; Proia LA; Kessler HA; Sha BE; Tarone RE; Poirier MC
AIDS; 1999 May; 13(8):919-25. PubMed ID: 10371172
[TBL] [Abstract][Full Text] [Related]
7. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
8. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
9. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.
Demas PA; Webber MP; Schoenbaum EE; Weedon J; McWayne J; Enriquez E; Bamji M; Lambert G; Thea DM
Pediatrics; 2002 Sep; 110(3):e35. PubMed ID: 12205285
[TBL] [Abstract][Full Text] [Related]
10. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
Taneepanichskul S; Sirinavin S; Phuapradit W; Chaturachinda K
Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):329-31. PubMed ID: 9325519
[TBL] [Abstract][Full Text] [Related]
11. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
[TBL] [Abstract][Full Text] [Related]
12. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
13. Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.
Neubert J; Pfeffer M; Borkhardt A; Niehues T; Adams O; Bolten M; Reuter S; Stannigel H; Laws HJ
BMC Pregnancy Childbirth; 2013 Jan; 13():22. PubMed ID: 23347580
[TBL] [Abstract][Full Text] [Related]
14. Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M
Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167
[TBL] [Abstract][Full Text] [Related]
15. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
17. In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
Lin SH; Wang Y; Hartley SW; Karyadi DM; Lee OW; Zhu B; Zhou W; Brown DW; Beilstein-Wedel E; Hazra R; Kacanek D; Chadwick EG; Marsit CJ; Poirier MC; Brummel SS; Chanock SJ; Engels EA; Machiela MJ;
AIDS; 2021 Aug; 35(10):1525-1535. PubMed ID: 33756513
[TBL] [Abstract][Full Text] [Related]
18. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
[TBL] [Abstract][Full Text] [Related]
19. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
[TBL] [Abstract][Full Text] [Related]
20. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.
Sperling RS; Shapiro DE; McSherry GD; Britto P; Cunningham BE; Culnane M; Coombs RW; Scott G; Van Dyke RB; Shearer WT; Jimenez E; Diaz C; Harrison DD; Delfraissy JF
AIDS; 1998 Oct; 12(14):1805-13. PubMed ID: 9792381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
